← All trials
NCT02604186
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 9, 2016
- Primary completion
- Mar 15, 2017
- Completion date
- Mar 15, 2017
- First posted
- Nov 13, 2015
- Last posted
- Nov 7, 2017
- Enrollment
- 55
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of CampinasLead sponsor
- Conselho Nacional de Desenvolvimento Científico e TecnológicoCollaborator
- Cristália Produtos Químicos Farmacêuticos Ltda.Collaborator
- University of CampinasOverall official - principal investigator
- University of CampinasReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.